Enzo Gallo

KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burden

Daniele Marinelli, Marco Mazzotta, Stefano Scalera et al. · Annals of Oncology · 2020 · 218 citations · Full text

Medicine, Lung Adenocarcinoma, Immunology +7

Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells

Rossella Loria, Giulia Bon, Valentina Perotti et al. · Oncotarget · 2014 · 80 citations · Full text

KEAP1 and TP53 Frame Genomic, Evolutionary, and Immunologic Subtypes of Lung Adenocarcinoma With Different Sensitivity to Immunotherapy

Stefano Scalera, Marco Mazzotta, Giacomo Corleone et al. · Journal of Thoracic Oncology · 2021 · 76 citations

Tp53 Frame Genomic, Cancer Immunosurveillance, Lung Adenocarcinoma +7

Preclinical model in HCC: the SGK1 kinase inhibitor SI113 blocks tumor progression<i>in vitro</i>and<i>in vivo</i>and synergizes with radiotherapy

Cristina Talarico, Lucia D’Antona, Domenica Scumaci et al. · Oncotarget · 2015 · 61 citations · Full text

Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer

Giovanni Sette, Valentina Salvati, Marcella Mottolese et al. · Cell Death and Disease · 2015 · 51 citations · Full text